The main targets of capmatinib include
The main target of capmatinib is METkinase, also known as muscle fibroblast growth factor receptor (Mesenchymal Epithelial Transition Factor). METKinase is a receptor tyrosine kinase that belongs to the tyrosine kinase family. Its normal function involves regulating biological processes such as cell growth, migration, differentiation, and survival.
Under normal physiological conditions, METkinase activates downstream signaling pathways by binding to its ligand myofibroblast growth factor (Hepatocyte Growth Factor, HGF) and participates in regulating the normal physiological functions of cells. However, under certain pathological conditions, abnormal activation of MET kinase is closely related to the occurrence and development of various cancers, including non-small cell lung cancer (NSCLC).

Capmatinib is unique in that it specifically inhibitsMETkinase activity. By binding to METkinase, capmatinib blocks the conduction of the METkinase signaling pathway, interferes with the growth, differentiation and migration of tumor cells, thereby inhibiting the progression of cancer.
For NSCLC patients who carry METexon14 skipping mutations, this mutation will lead to abnormal activation of MET kinases and become a driving factor for lung cancer. Therefore, the targeting effect of capmatinib has significant efficacy in this specific patient group, providing them with an individualized and targeted treatment option.
Capmatinib is not currently available in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)